200
Participants
Start Date
June 2, 2021
Primary Completion Date
October 1, 2026
Study Completion Date
October 1, 2026
clinical, neuroimaging and DNA assessments
Selected assessments, including evaluation of treatment response to specific antipsychotic drugs, will be performed at follow-up visits after 1, 3 and 5 years
NOT_YET_RECRUITING
CHRU de Lille, Lille
NOT_YET_RECRUITING
CHU de Nice, Nice
RECRUITING
Pitié Salpétrière, Paris
NOT_YET_RECRUITING
CHU de Rouen, Rouen
NOT_YET_RECRUITING
CHU de Rouvray, Rouen
NOT_YET_RECRUITING
Fondation Vallée, Gentilly, Gentilly
Assistance Publique - Hôpitaux de Paris
OTHER